SCHEMBL19832452

SCHEMBL19832452

CN(CCOC(=O)C(C)(C)C)C(=O)OCCl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 5/20 0.40
CHRNB2 P17787 2/20 0.40
CHRNA4 P43681 2/20 0.40
CHRM4 P08173 2/20 0.40
CHRM5 P08912 2/20 0.40
CHRM1 P11229 2/20 0.40
CHRM3 P20309 2/20 0.40
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
BCHE P06276 3/20 0.33
PRKCA P17252 1/20 0.32
ALDH1A1 P00352 1/20 0.31
DNM1 Q05193 1/20 0.30
LMNA P02545 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18982352 0.80 CHRNB2 (0.44) CHRM2CHRNB2CHRNA4CHRM4CHRM5
SCHEMBL12120221 0.79 CHRM2 (0.56) CHRM2CHRNB2CHRNA4CHRM4CHRM5
SCHEMBL19832446 0.76 POLB (0.39) CHRM2CHRNB2CHRNA4CHRM4CHRM5
SCHEMBL21155602 0.76 CHRNB2 (0.33) CHRM2CHRNB2CHRNA4CHRM4CHRM5
SCHEMBL65921 0.75 POLB (0.41) CHRM2CHRNB2CHRNA4CHRM4CHRM5
SCHEMBL22651094 0.75 PDK2 (0.36) CHRM2CHRNB2CHRNA4CHRM4CHRM5
SCHEMBL300 0.74
SCHEMBL12987935 0.74 CHRNB2 (0.39) CHRM2CHRNB2CHRNA4CHRM4CHRM5
SCHEMBL19148674 0.73 PDK2 (0.38) CHRM2CHRNB2CHRNA4CHRM4CHRM5
SCHEMBL65194 0.73 CHRM2 (0.46) CHRM2CHRNB2CHRNA4CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018022529-A1 PANTETHEINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGIC DISORDERS Retrophin, Inc. (US) 2018-02-01 WO disclosed